NCT03036098 2026-03-06CheckMate901Bristol-Myers SquibbPhase 3 Active not recruiting1,314 enrolled 23 charts 1 FDA
NCT02516241 2026-01-28Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial CancerAstraZenecaPhase 3 Active not recruiting1,126 enrolled 52 charts
NCT04223856 2025-06-13EV-302Astellas Pharma IncPhase 3 Active not recruiting886 enrolled 12 charts 1 FDA